We describe a direct method for determining four sulfates and seven glucuronides of 17-oxosteroids (1 70S) in urine without hy&olysis, by use of "hii-performance" liquid chromatography (HPLC) with fluorometric detection. After pretreatment of urine samples with a Sep-Pak C18 cartridge, four 170S sulfates and seven 170S glucuronides in the pretreated urine samples were reacted with tetrapentylammonium ions to form ion pairs. Ion Heretofore, no method has been reported for extracting urinary 170S glucuronides such as liOHA glucuronide, 11OHE glucuronide, DHEA glucuronide, 11COA glucuronide, or 11COE glucuronide, and separating them by HPLC. These glucuronides are difficult to extract without containination with other urinary components. However, we have developed a method in which i7OS sulfates and 17OS glucuronides in urine form ion pairs with tetrapentylainmonium ions (WA). Ion-paired 17OS sulfates are extracted from urine with benzene with no concurrent extraction of the ion-paired 170S glucuronides. Ion-paired 17OS glucuromdes remaining in the urine are then extracted with dichloromethane. These ion pairs are labeled with dansylhydrazine as dansylhydrazone under reaction conditions improved by us, and these hydrazones are measured separately by HPLC with fluorescence spectrophotometry and a Capcell-Pak C8 column.
Reagents
Reagents were as follows: WA bromide (Aldrich Chemical Co., Milwaukee, WI 53233), 0.1 mol/L, in water; dansylhydrazine (5-dimethylaminonaphthalene-1-sulfonylhydrazine; Aldrich Chemical Co.), 2 g/L, in acetonitrile, and stored at 4#{176}C until use; and borate buffer, 0.4 mol/L, pH 9.0.
To prepare the stock standard solution we dissolved separately, each in 10 mL of distilled and then de-ionized water, 1 All other reagents and solvents, of analytical reagent grade or HPLC grade, were purchased from commercial sources.
Procedures

Pretreatment of urine samples with Sep -Pak C18 cartridge.
Centrifuge urine samples for 5 mm at 400 x g, pass 1.5 mL through the Sep-Pak C18 cartridge, then wash the cartridge with 5 mL of water. (The cartridge was activated with 5 mL of methanol and washed with 20 mL of water before use.) Elute, with 3 mL of methanol, the 170S sulfates and glucuronides adsorbed on the cartridge, and evaporate the eluate under reduced pressure.
Extraction
oil 70S
sulfates. Dissolve each residue in 0.5 mL of water, then add 0.6 mL of borate buffer and 0.4 mL of WA solution,and mix. Add 3 mL of benzene to the mixture, shake for 30s, and centrifuge the mixture for 10 mm at 700 x g. Transfer 2 mL of the benzene layer to a glass-stoppered test tube and evaporate the benzene under reduced pressure; this leaves ion pairs of 170S sulfates with TPA. Discard the benzene layer remaining on the aqueous layer.
Extraction of 1 70S glucuronides. Add 0.4 g of sodium sulfate to the aqueous layer and mix. Dissolve the sulfate by placing the mixture in a water bath at 50#{176}C, then cool at room temperature. Add 3 mL of dichloromethane to the aqueous solution, shake for 1 rein, and centrifuge for 10 mm at 1100 x g. Transfer 2 mL of the dichloromethane layer to another glass-stoppered test tube and evaporate under reduced pressure as above, leaving ion pairs of 170S glucuronides with WA.
Labeling. To label the ion pairs, add 0.2 mL of dansylhydrazine solution and 0.05 mL of acetic acid to the extracted ion pairs, and mix. Evaporate the solvent from each mixture under reduced pressure at 50#{176}C. After letting the residue stand for 20 mm for 170S sulfates, 10 mm for 170S glucuronides, each at 50 #{176}C, dissolve it in 100 L of acetonitrile, and inject a sample (5-iO pL for normal concentrations) into the chromatograph.
Chromatographic
conditions. We separated i7OS sulfates on a Capcell-Pak C8 column at 30 #{176}C, using mobile-phase solvent A at a flow rate of 1 mL/min. We separated 170S glucuronides at 55 #{176}C, using the same flow rate, and using a solvent exchanger to change the mobile-phase solvent from B to C 45 mm after injection of the sample solution. In both assays, we monitored the column effluent with a fluorometnc detector, using an excitation wavelength of 330 nm and an emission wavelength of 535 nm.
Optimization of the Assay
Determination of the urine sample volume to be added to the Sep-Pak C18 cartridge. To 4 mL of a concentrated solution of steroids containing 32 ig of each steroid, we added 16 mL of urines pooled from three patients, and applied 1, 2, 3, 4, or 5 mL of the mixture to a Sep-Pak C18 cartridge. We washed the cartridge with 5 mL of water and eluted the adsorbed steroids with 3 mL of methanol. After evaporating the methanol under reduced pressure, we quantified the 170S sulfates and 170S glucuronides in the residues as described above.
Optimal elution of 1 70S sulfates and glucuronides from Sep-Pak C18 cartridges. We applied to a Sep-Pak C18 cartridge 2.5 mL of steroids solution, containing 1.6 pg each of 170S sulfates and 1.6 pg each of 170S glucuronides, and the cartridge adsorbed the steroids. It was washed with 5 mL of water and eluted with 1, 2, 3, 4, or 5 mL of methanol.
We then evaporated the methanol under reduced pressure, and measured the 170S sulfates and glucuronides in the residues by the proposed method.
Procedure for determination of percent extractionof 170S sulfates and glucuronides.
Quantities listed in parentheses were used when THA solution is used; the procedure shown in brackets was used when sodium sulfate was added in the procedure detailed below.
For the first extraction, add 2.4 mL (4 mL) of borate buffer and The percent extraction obtained by each combination of quaternary ammonium ion and solvent was calculated as follows: (amount of steroid extracted by the first extraction) total amount of steroid extracted) x 100. Extraction was complete when the combination of THA and dichloromethane was used, as proved by results of the triple extraction.
Comparison Method
Hydrolysis of sulfates and glucuronides of I 70S. 17OS
sulfates and glucuronides were hydrolyzed by solvolysis (6) and with /3-glucuronidase (12) , respectively. Labeling reaction of free 17OS. The 170S in each residue, labeled by the dansylhydra.zine method of Kawasaki et al. (11) , were dissolved in 100 1zL of chloroform, of which an aliquot was injected into the chromatograph.
HPLC conditions. We separated the 170S by chromatography on a column of Zorbax SIL, 4.6 (i.d.) x 250 mm, at 25#{176}C, using the organic layer separated from the mixture of dichloromethane, ethanol, and water (400/7/7 by vol) as the mobile phase. We monitored the effluent from the column, using a fluorometric detector at an excitation wavelength of 350 rim and an emission wavelength of 505 nm (11).
Results and Discussion
Optimization of Assay Conditions
Volume of urine sample applied to the Sep-Pak C18 cartridge. Experiments were done to determine the adequate urine volume for the Sep-Pak C18 cartridge by using the urine sample with added 170S conjugates (each conjugate: 1.6 pg/mL; total: 17.6 p.g/mL) as described above. When urine volumes were <3 mL, the 170S sulfates and glucuromdes were ftilly adsorbed; use of volumes greater than 4 mL resulted in incomplete steroid adsorption (Figure 1) .
Washing cartridge-absorbed 1 7OS sulfates and glucuronides with water. To determine any loss of steroids from the column caused by washing it with water, we washed the cartridge with different volumes of water (from 1 to 10 mL). The water eluted no steroids from the cartridge. Kawasaki et al. (15) proposed washing columns with 5 mL of water, followed by 3 mL of ethanol (200 mLIL volume for elution of all 11 conjugates (each 4 jig, total 44 pg) adsorbed on the cartridge as described above, we eluted the cartridge with 1 to 5 mL of methanol after washing with 5 mL of water. The four 170S sulfates were fully (97.5-99.3%, n = 3) eluted with 1 mL of methanol (99.0-100.6% with 2 mL, 98.8-101.5% with 3 to 5 mL, each n = 3), but elution of the seven 170S glucuromdes was only 75.3-90.0% complete with 1 mL of methanol, 95.8-97.1% with 2 mL, 98.0-99.3% with 3 mL, and 98.5-100.2% with 4 to 5 mL (each n = 3). We chose 3 mL of methanol as the optimal minimum elution volume. Extraction efficiency of 170S sulfates and glucuronides. To find a combination of counter ion and solvent that could separately extract 170S sulfates and 17OS glucuronides from urine samples, we examined the extraction of DHEA sulfate, Ad sulfate, Ad glucuronide, 11COE glucuronide, and 11OHA glucuronide, using various combinations of counter ions with an organic solvents. The counter ions we examined were BTEA, BTBA, TEA, WA, and THA; and benzene, 1,2-dichloroethane, and dichloromethane were examined as solvents. Because THA is less soluble (approximately 0.01 moLIL at room temperature) than the other counter ions, we used the quantities of reagents described above.
The results of this experiment (Table 1) Table 1 sulfates were extracted from the standard solution containing all 11 of the sulfates and glucuronides, followed by extraction of the 170S glucuronides as proposed, 100% of the 170S sulfates was extracted with no concurrent extraction of 170S glucuronides, and 100% of the 170S glucuronides was also extracted from the remaining solution, as shown in Figure 2 .
Optimum pH extraction of 170S sulfates and 1 70S glucuronides. To determine the pH at which extraction of 170S sulfates and 170S glucuromdes was optimal, we adjusted the pH of a mixture of five volumes of sample (4 mg/L each of DHEA sulfate and Ad glucuronide) and one volume of WA solution of pH 6, 7, 8, 9, 10, 11, or 11.5 with phosphate buffer (pH 6, 7, and 8) or borate buffer (pH 9, 10, 11, and The labeling reaction proceeded more rapidly in acetonitrile and ethanol than in benzene, but including ethanol in the reacting solvent and use of ethanol as the solvent for dansylated samples resulted in some nonsteroidal peaks appearing in the chromatogram. These peaks increased with the time at room temperature, and they were not seen when we used acetonitrile as the sole solvent during labeling and as the solvent of dansylated Within-and between-run precision. The within-day CVs determined from 10 repeated measurements of the 170S sulfates in urine samples and in urine samples with 170S sulfates and glucuronides added (500 and 1000 .tgfL, final concentration) ranged respectively from 1.87% to 3.02% and from 2.09% and 3.46%. Similarly, for the 170S glucuronides in the same samples, the CVs ranged from 3.26% to 4.34% and 3.48% to 4.98%, respectively. The between-day CVs, determined once daily on 10 successive days, ranged from 2.77% to 4.50% for 170S sulfates and from 3.61% to 5.80% for 170S glucuronides. (Table  2) .
Results for Patients and Healthy Men
Typical chromatograms from urine samples. Typical chromatograms of 170S sulfates in urine from a patient with Cushing's syndrome and from a healthy man are shown in Figure 3 . Figure 4 shows chromatograms of 170S glucuronides in their urine. Each steroid is clearly separated and identified.
Daily excretion of 170S sulfates and glucuronides. The daily excretion rates for urinary 170S sulfates and glucuronides in 100 healthy men whose health was determined by thorough medical examination are shown in Table 3 . A patient with Cushing's syndrome showed a striking increase in the daily excretion of DHEA sulfates and Ec sulfate (Table 3 and Figure 3) ; his excretion of 11OHA glucuromde, 11OHE glucuronide, and 11COE glucuromde increased, but Table 3) . This indicates that the correct inforination for individual 170S sulfates and glucuronides is lost by the hydrolysis.
The daily excretion of 170S glucuronides in a patient with aldosteronism was lower than that in healthy men. 
